Literature DB >> 2413240

[Therapy of herpetic diseases of the anterior eye segment].

R Sundmacher.   

Abstract

Clinico-virologic investigations and the availability of the new antiviral drug Acyclovir have changed our therapeutic approach to deep herpetic diseases. Treatment of the symptoms alone with steroids should now be avoided. Basic treatment should consist of optimal dosages of Acyclovir. However, additional steroid therapy is still necessary. Significant progress in the treatment of dendritic keratitis is to be expected as soon as high-titer interferon preparations become commercially available. Treatment of dendritic keratitis with a combination of a modern antiviral drug and high-titer interferon will reduce the average time the corneal epithelium takes to heal from the present 6 days to 3 days. While considerable progress has been made in the treatment of herpes, no more than a step in the right direction has been taken with herpes zoster varicellosus virus, owing to its greater resistance to Acyclovir.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2413240     DOI: 10.1055/s-2008-1050949

Source DB:  PubMed          Journal:  Klin Monbl Augenheilkd        ISSN: 0023-2165            Impact factor:   0.700


  2 in total

1.  [Therapy refractory stromal Herpes keratitis under aciclovir].

Authors:  C Spira; N Szentmáry; A Hasenfus; M Sauter; S Smola; B Seitz
Journal:  Ophthalmologe       Date:  2014       Impact factor: 1.059

2.  ["Herpetic keratitis". Various expressions require different therapeutic approaches].

Authors:  B Seitz; A Heiligenhaus
Journal:  Ophthalmologe       Date:  2011-04       Impact factor: 1.059

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.